Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma

Tomer Meirson, Victoria Neiman, Michal Sternschuss, Gal Markel, Ian F. Tannock

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)e489
JournalThe Lancet Oncology
Volume23
Issue number11
DOIs
StatePublished - Nov 2022
Externally publishedYes

Cite this